Topica Pharmaceuticals Inc
Funding rounds
1 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Oct 2011 | $32 M | No. 1 | $10 to $50 million | equity | SEC |
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Topica Pharmaceuticals Inc chose not to state its revenue in its newest notice of a funding round (Jun 2013).
SEC Form D · Jun 2013
The industry group it chose in its notices: Pharmaceuticals.
SEC Form D · Jun 2013
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Topica Pharmaceuticals Inc is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Charles Gregory Vontz | Executive officer | Jun 2013 |
| Joseph Kirk Golemme | Executive officer | Jun 2013 |
| Catherine E. De Porceri-Morton | Executive officer | Oct 2011 |
| Joseph E. Golemme | Executive officer | Oct 2011 |
| Norifumi E. Nakamura | Executive officer | Oct 2011 |
| Charles Gregory Homcy, MD | Director | Jun 2013 |
| Charles Gregory Vontz | Director | Jun 2013 |
| David Kirk Cohen, MD | Director | Jun 2013 |
| G. Kirk Raab | Director | Jun 2013 |
| Russell Gregory Hirsch, MD, Ph.D. | Director | Jun 2013 |
| Alex Gregory Barkas | Director | Oct 2011 |
| Charles Gregory Homcy MD | Director | Oct 2011 |
| David E. Cohen MD MPH | Director | Oct 2011 |